 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 15 | 5 | 20 | | 1997 | 25 | 2 | 27 | | 1998 | 13 | 2 | 15 | | 1999 | 11 | 2 | 13 | | 2000 | 16 | 1 | 17 | | 2001 | 14 | 7 | 21 | | 2002 | 38 | 8 | 46 | | 2003 | 22 | 3 | 25 | | 2004 | 33 | 4 | 37 | | 2005 | 37 | 3 | 40 | | 2006 | 38 | 9 | 47 | | 2007 | 44 | 8 | 52 | | 2008 | 38 | 6 | 44 | | 2009 | 38 | 4 | 42 | | 2010 | 49 | 3 | 52 | | 2011 | 41 | 4 | 45 | | 2012 | 59 | 5 | 64 | | 2013 | 67 | 12 | 79 | | 2014 | 72 | 9 | 81 | | 2015 | 64 | 9 | 73 | | 2016 | 83 | 8 | 91 | | 2017 | 79 | 9 | 88 | | 2018 | 88 | 9 | 97 | | 2019 | 81 | 4 | 85 | | 2020 | 75 | 6 | 81 | | 2021 | 77 | 2 | 79 | | 2022 | 90 | 1 | 91 | | 2023 | 86 | 2 | 88 | | 2024 | 56 | 5 | 61 | | 2025 | 59 | 2 | 61 | | 2026 | 16 | 0 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, Chang JY, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Levy B, Lin J, Loo BW, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patil T, Polanco PM, Riess J, Mendez ALR, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yau E, Yun K, Gregory K, Hang L. Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 04; 24(4).
-
Hinz TK, Le AT, Doan T, Ast A, Jaramillo S, Avila JT, Skhisov D, Haines S, Navarro AC, Patil T, Nemenoff RA, Heasley LE. Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. Cancer Lett. 2026 Jun 28; 648:218467.
-
Besse B, Subbiah V, Curigliano G, Bowles DW, Doebele RC, Mansfield AS, Baik CS, de Lima Lopes G, Paz-Ares L, Taylor MH, Tan DSW, Alonso G, Gadgeel SM, Kalemkerian GP, Ou SI, van der Wekken AJ, Becerra CR, Evangelist M, Griesinger F, Liu SV, Lou Y, Mazières J, Melear JM, Narang M, Saxena A, Thomas M, Wang S, Thomassen A, Lee DH, Kim DW, Gainor JF. Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. J Clin Oncol. 2026 May; 44(13):1190-1197.
-
Faseh L, Fruhling P, Taflin H, Lundmark Rystedt J, Williamsson C, Hemmingsson O, Björnsson B, Gerling M, Sparrelid E, Sandström P, Hasselgren K, Engstrand J. Real-world management of patients with simultaneously diagnosed synchronous liver and lung metastatic colorectal cancer - a national cohort study. Acta Oncol. 2026 Mar 12; 65:201-212.
-
Christenson JL, Spoelstra NS, Williams MM, Logan LL, O'Neill KI, Orlicky DJ, Baker NT, Wagner JA, Staley AW, Van Bokhoven A, Goodspeed A, Kuo LW, Crump LS, Diamond JR, Richer JK. Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth. Cancer Res Commun. 2026 04 01; 6(4):750-768.
-
Carter-Bawa L, Ostroff JS, Rawl SM, Hirsch EA, Banerjee SC, Ciupek A, Comer RS, Kale M, Leopold KT, Monahan PO, Slaven JE, Valenzona F, Wiener RS, Vielma AG. Leveraging Social Media to Achieve Population-Level Reach of Lung Cancer Screening-Eligible Individuals: A RE-AIM Framework Perspective. J Med Internet Res. 2026 Mar 03; 28:e80281.
-
Carter-Bawa L, Williamson TJ, Alvey N, Begnaud A, Boatman D, Brown DP, Cook D, Donaldson D, Feldman J, Hamann HA, Kazerooni E, Kearney L, Manley E, Moghanaki D, Ostroff JS, Pantelas J, Park ER, Rigney M, Rosenthal L, Scharnetzki E, Shiller J, Smith RA, Stangl AL, Warner ET, Wood DE, Studts JL. Confronting nihilism and stigma in lung cancer: The nurse practitioner's role in restoring hope and trust. J Am Assoc Nurse Pract. 2026 Mar 01; 38(3):146-153.
-
Martin-Martin A, Chipón C, Guzman-Kunstmann C, Guzman-Kunstmann S, Buelvas N, Henríquez C, Vidal F, Villarroel-Espindola F, Hinz TK, Heasley LE, López-Muñoz RA. The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation. Biol Res. 2026 Feb 19; 59(1).
-
He K, Forde PM, Govindan R, Santoro A, Gettinger S, Borghaei H, Spira A, Chu Q, Zinner R, Schoenfeld AJ, Camidge DR, Spigel DR, Gurpide A, Juergens RA, Laurie SA, Cerra M, Spires T, Greenawalt DM, Rapoport I, Gainor JF. Fast Real-Time Assessment of Combination Therapies in Immuno-ONcology in patients with advanced non-small-cell lung cancer (FRACTION-Lung). ESMO Open. 2026 Mar; 11(3):106078.
-
Borok MZ, Fiorillo S, Manyeruke F, Makoni T, Gudza I, Mutimuri M, Phiri M, Nyagura T, White IE, Rapaport R, Bock A, Nalwoga A, Campbell TW, Campbell TB. Improved screening for pulmonary Kaposi sarcoma in a low-resource setting. AIDS. 2026 Jun 01; 40(6):744-752.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|